Receive E-mail Alerts
SEC Filing Keyword Search
(
View search tips
)
Groupings Filter
(
View SEC Groupings descriptions
)
All Forms
3,4,5
Annual Filings
Current Reports
Mergers & Acquisitions
Other
Proxy Filings
Quarterly Filings
Registration Statements
View Section 16 Filings (3,4,5)
<< First
| Previous
|
Next
|
Last
>>
Filing Date
Form
Description
Filing Group
Downloads
11/13/09
SC TO-I
Tender offer schedule and amendment filed by the issuer.
Other
11/05/09
10-Q
Quarterly report which provides a continuing view of a company's financial position
Quarterly Filings
11/05/09
8-K
Report of unscheduled material events or corporate event
Current Reports
11/02/09
4
Statement of changes in beneficial ownership of securities
3,4,5
10/02/09
4
Statement of changes in beneficial ownership of securities
3,4,5
10/02/09
4
Statement of changes in beneficial ownership of securities
3,4,5
09/28/09
8-K
Report of unscheduled material events or corporate event
Current Reports
09/24/09
4
Statement of changes in beneficial ownership of securities
3,4,5
09/24/09
4
Statement of changes in beneficial ownership of securities
3,4,5
09/24/09
4
Statement of changes in beneficial ownership of securities
3,4,5
<< First
| Previous
|
Next
|
Last
>>
MAXY (Common Stock)
Exchange
NASDAQ
(US Dollar)
Price
$5.62
Change
(%)
0.04
(0.72%)
Volume
184,664
Data as of 11/20/09 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Investor Relations Contact:
650-298-5486
info@maxygen.com
Corporate Presentation
Download
PDF
Corporate Overview
Strategic Alliances
Leadership
Corporate Governance
Protein Therapeutics
Vaccines
Pipeline
Maxy Alpha
Maxy-G-CSF
Maxy-Factor VII
Maxy-Gamma
Our Platform
Patents
Publications
Scientific Advisory Board
Maxygen News
Financial Reconciliations
Webcasts
Stock Information
Analysts
Annual Reports
SEC Filings
Email Alerts
FAQ
Information Request
Proxy Materials
Job Opportunities
Our Benefits
Our Principles
